Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-25-245483
Filing Date
2025-10-22
Accepted
2025-10-21 19:25:20
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1 d19490ds1.htm S-1 394017
2 EX-5.1 d19490dex51.htm EX-5.1 16241
3 EX-23.1 d19490dex231.htm EX-23.1 1887
4 EX-23.2 d19490dex232.htm EX-23.2 1987
5 EX-FILING FEES d19490dexfilingfees.htm   iXBRL EX-FILING FEES 18473
6 GRAPHIC g19490g03a37.jpg GRAPHIC 51709
7 GRAPHIC g19490g51l69.jpg GRAPHIC 9683
  Complete submission text file 0001193125-25-245483.txt   632031

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d19490dexfilingfees_htm.xml XML 5132
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-291002 | Film No.: 251408310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)